EMA — authorised 30 April 1996
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
EMA authorised Humalog on 30 April 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 30 April 1996.
Eli Lilly Nederland B.V. holds the EU marketing authorisation.